- Home
- HKD vs CTMX Comparison
HKD vs CTMX Comparison
Compare HKD & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HKD
- CTMX
- Stock Information
- Founded
- HKD 2003
- CTMX 2008
- Country
- HKD France
- CTMX United States
- Employees
- HKD N/A
- CTMX N/A
- Industry
- HKD Finance: Consumer Services
- CTMX Biotechnology: Pharmaceutical Preparations
- Sector
- HKD Finance
- CTMX Health Care
- Exchange
- HKD Nasdaq
- CTMX Nasdaq
- Market Cap
- HKD 656.8M
- CTMX 596.2M
- IPO Year
- HKD 2022
- CTMX 2015
- Fundamental
- Price
- HKD $1.66
- CTMX $3.51
- Analyst Decision
- HKD
- CTMX Strong Buy
- Analyst Count
- HKD 0
- CTMX 5
- Target Price
- HKD N/A
- CTMX $5.80
- AVG Volume (30 Days)
- HKD 233.8K
- CTMX 4.1M
- Earning Date
- HKD 01-01-0001
- CTMX 11-06-2025
- Dividend Yield
- HKD N/A
- CTMX N/A
- EPS Growth
- HKD 9.93
- CTMX 263.20
- EPS
- HKD 0.23
- CTMX 0.49
- Revenue
- HKD $20,445,000.00
- CTMX $141,100,000.00
- Revenue This Year
- HKD N/A
- CTMX N/A
- Revenue Next Year
- HKD N/A
- CTMX N/A
- P/E Ratio
- HKD $7.25
- CTMX $6.93
- Revenue Growth
- HKD N/A
- CTMX 18.01
- 52 Week Low
- HKD $1.55
- CTMX $0.40
- 52 Week High
- HKD $3.79
- CTMX $3.91
- Technical
- Relative Strength Index (RSI)
- HKD 40.49
- CTMX 63.35
- Support Level
- HKD $1.61
- CTMX $3.17
- Resistance Level
- HKD $1.80
- CTMX $3.91
- Average True Range (ATR)
- HKD 0.09
- CTMX 0.25
- MACD
- HKD -0.01
- CTMX -0.01
- Stochastic Oscillator
- HKD 19.24
- CTMX 52.95
About HKD AMTD Digital Inc. (every five of which represent two)
AMTD Digital Inc along with its subsidiaries, is mainly involved in the provision of digital solutions services. Its reportable segments are digital solutions services segment, hotel operations, hospitality and VIP services segment and media and entertainment services. The company generates maximum revenue by providing financial digital solutions through its insurance brokerage services and other digital solutions services. Geographically, the company generates maximum revenue from Hong Kong and Singapore.
About CTMX CytomX Therapeutics Inc.
CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.